Bouter, K. E. C. (2021). Therapeutic targets in type 2 diabetes and metabolic syndrome: From microbiome to medication. [Thesis, fully internal, Universiteit van Amsterdam].
van Baar, A. C. G. (2021). Endoscopic duodenal hydrothermal ablation for the treatment of type 2 diabetes mellitus. [Thesis, fully internal, Universiteit van Amsterdam].
van de Laar, A. W. J. M. (2021). Analyses of weight loss after bariatric surgery. [Thesis, fully internal, Universiteit van Amsterdam].
de Groot, P. F. (2021). Trust your gut... Microbes: Faecal microbiota transplantation in metabolic, autoimmune and infectious disease. [Thesis, fully internal, Universiteit van Amsterdam].
Bakker, G. J. (2020). Generating understanding in diabetes & obesity: The gut microbiota as a new player in metabolism. [Thesis, fully internal, Universiteit van Amsterdam].
de Clercq, N. C. (2020). Gut microbiota in host metabolism and cancer: From biological pathways to novel treatment strategies. [Thesis, fully internal, Universiteit van Amsterdam].
Hartstra, A. V. (2020). Do you have the guts to be happy? Role of the gut-brain axis and gut microbiota in human metabolism. [Thesis, fully internal, Universiteit van Amsterdam].
Surendran, R. P. (2019). Molecular metabolism underlying hypertriglyceridemia: From bench to bedside. [Thesis, fully internal, Universiteit van Amsterdam].
Smits, L. P. (2019). From image to intervention: Innovation in cardiometabolic medicine. [Thesis, fully internal, Universiteit van Amsterdam].
Kootte, R. S. (2018). The role of the intestine in human glucose and lipid metabolism: Source for novel targets in the prevention of cardiometabolic disease. [Thesis, fully internal, Universiteit van Amsterdam].